<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001878'>Hemolytic anemia</z:hpo> and pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath> (PRCA) after allogeneic hematopoietic stem cell transplantation (HSCT) have been reported to be mainly related to <z:e sem="disease" ids="C0860218" disease_type="Disease or Syndrome" abbrv="">ABO-incompatibility</z:e> between donor and recipient </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001890'>Autoimmune hemolytic anemia</z:hpo> (AIHA) without <z:e sem="disease" ids="C0860218" disease_type="Disease or Syndrome" abbrv="">ABO-incompatibility</z:e> has been also reported after allogeneic HSCT, especially with T-cell <z:mpath ids='MPATH_63'>depletion</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>However, optimal management of AIHA or PRCA remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>A 54-year-old male with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) underwent haploidentical human leukocyte antigen-mismatched HSCT using in vivo alemtuzumab and developed AIHA and PRCA simultaneously 15 months after transplantation, following the administration of cidofovir and probenecid for persistent cytomegalovirus (CMV) antigenemia and <z:e sem="disease" ids="C0035333" disease_type="Disease or Syndrome" abbrv="">retinitis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>AIHA was successfully treated with rituximab, and subsequently PRCA with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> without relapse of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or recurrence of <z:e sem="disease" ids="C0010823" disease_type="Disease or Syndrome" abbrv="">CMV infection</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The clinical course suggested that AIHA was mainly caused by humoral immune response, while PRCA was mainly caused by cell-mediated immune response in this patient, although these immune responses might be related to each other </plain></SENT>
</text></document>